Buradasınız

SİTOSTEROLEMİ (B-SİTOSTEROLEMİ)

SITOSTEROLEMIA (B-SİTOSTEROLEMIA)

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
Aim: Sitosterolemia -also known as phytosterolemia- is a rare autosomal, recessively inherited dis¬ease characterized by elevated plasma and tissue plant sterol concentrations. Sitosterolemia is char¬acterized by tendon and tuberous xanthomas and by a strong propensity toward premature coro¬nary atherosclerosis. In this article information concerning sitosterolemia disease are reviewed. Main Main Findings: In contrast to healthy subjects with total plasma plant sterols less than 1 mg/dl, patients with sitosterolemia have plasma phytosterol levels in the range of 12 to 40 mg/dl. The main plant sterols in patients with phytosterolemia are sitosterol and kampesterol but also elevated levels of stigmasterol, avenasterol, brassikasterol, kampestanol, sitostanol are found. Sitosterolemia has been shown to result from mutations in either of the genes for 2 proteins (ABCG5 or ABCG8). These ABC transporters preferentially pump plant sterols out of intestinal cells into the gut lumen, thereby decreasing sterol absorption. Results: We believe that it is important to measure blood sitosterol lev¬els in suspicious patients in order to get correct diagnosis and treatment the sitosterolemia.
Abstract (Original Language): 
Amaç: Sitosterolemi; fitosterolemi olarak da adlandırılan, artmış plazma ve doku sterol konsantras-yonuyla karakterize, çok nadir görülen otozomal resesif kalıtsal bir hastalıktır. Erken koroner ateroskleroza eğilim gösteren, tendon ve tüberoz ksantomlarıyla karakterizedir. Bu makalede sitos¬terolemi hastalığı ile ilgili bilgiler derlenmiştir. Ana Bulgular: Sağlıklı kişilerde total plazma bitki sterol konsantrasyonu İmg/dl'den daha az olduğu halde, sitosterolemi hastalarında bu oran 12-40 mg/dL kadar yükselmektedir. Sitosterolemi hastalarında, bitki sterolleri olarak başta sitosterol ve kampesterol artmış olmasına rağmen, aynı zamanda stigmasterol, avenasterol, brassikasterol, kampestanol ve sitositanol da bulunur. Sitosterolemi'nin ABCG8 ve ABCG5 proteinleri için genlerin herhangi birinde mutasyonlardan kaynaklandığı belirlenmiştir. ATP-bağlayıcı kaset (ABC) transport proteinleri bitki sterollerini intestinal hücrelerde bağırsak lümeni içerisine geri pompalayarak, sterol absorpsiyonunu azaltırlar. Sonuç: Sitosterolemi hastalığının teşhis ve tedavisinde yanılmamak için, şüpheli kişilerde mutlaka sitosterollerin ölçülmesi gerektiği kanaatindeyiz.
171-

REFERENCES

References: 

1. Salen G, von Bergmann K, Lütjohann D, Kwiterovich P, Kane J, Patel SB et al. Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia. Circulation 2004; 109(8):966-71.
2. Sudhop T, Bergmann KV. Sitosterolemia - a rare disease are elevated plant sterols an additional risk factor?. Z Kardiol 2004; 93:921-28.
3. Patel SB, Klett EL, Anh GS, Yu H, Chen J, Pandit B
et al. Sitosterolemia; of mice and man. International Conqress Series 2004; 1262:300-04.
4. Heimer S, Langmann T, Moehle C, Mauerer R, Dean M, Beil FU et al. Mutations in the human ATP-binding cassette transporters ABCG5 and ABCG8 in sitosterolemia. Human Mutation 2002; 20(2): 151.

5. Lee MH, Lu K, Hazard S, Yu H, Shulenin S, Hidaka
H et al. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nature genetics 2001; 27:79-83.
6. Hubacek JA, Berge KE, Cohen JC, Hobbs HH.
Mutations in ATP-cassette binding proteins G5 (ABCG5) and G8 (ABCG8) causing sitosterolemia. Human Mutation 2000; 18(4):359-60.
7. Berge KE, Tian H, Graf GA, Yu L, Grishin NV,
Schultz J et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Comment In Science 2000; 290(5497):1709-11.

8. Lu K, Lee MH, Hazard S, Brooks-Wilson A, Hidaka H, Kojima H et al. Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. American Journal Of Human Genetics 2001; 69(2): 278-90.
9. Lee MH, Lu K, Patel SB. Genetic basis of sitos-terolemia. Current Opinion In Lipidology 2001; 12(2):141-9.
10. Bhattacharyya AK, Connor WE. _Sitosterolemia and xanthomatosis. A newly described lipid stor-age disease in two sisters, J.Clin.Invest 1974; 53(4):1033-43.
11. Salen, G, Tint GS, Shefer S, Shore V, Nguyen L. Increased sitosterol absorption is offset by rapid elimination to prevent accumulation in heterozy-gotes with sitosterolemia. Arteriosclerosis And Thrombosis 1992; 12(5), 563-8.
12. Patel SB, Salen G, Hidaka H, Kwiterovich PO,
Stalenhoef AF, Miettinen TA et al. Mapping a gene involved in regulating dietary cholesterol absorp¬tion. The sitosterolemia locus is found at chromo¬some 2p21, The Journal Of Clinical Investigation
1998; 102(5):1041-4.
13. Salen G, Horak I, Rothkopf M, Cohen JL, Speck J, Tint GS et al. Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitosterolemia with xanthomatosis. J. Lipid Res
1985; 26: 1126-33.
14. Kuksis A. Plasma non-cholesterol sterols. Journal of
Chromatography A 2001; 935(1-2): 203-36.
15. Igel M, Giesa U, Lutjohann D, von Bergmann K. Comparison of the intestinal uptake of cholesterol, plant sterols, and stanols in mice. Journal Of Lipid
Research 2003;44(3):533-8.
16. Moghadasian MH, Frohlich JJ. Effects of dietary phytosterols on cholesterol metabolism and ather¬osclerosis: clinical and experimental evidence. The
American Journal of Medicine 1999; 107(6): 588¬94.
17. Schaller H. Prog. Lipid Res 2003; 42:163-75.
18. Turley SD, Dietschy JM. Sterol absorption by the small intestine. Lippincott Williams & Wilkins 2003;
14(3):233-40.
19. Sinsabaugh RL, Antibus RK, Jackson CR, Karpanty S, Robinson M, Liptak M et al. A _-Sitosterol Assay For Fine-Root Mass In Soils. Soil Biol. Biochem
1996; 29(1):39-44.
20. Hidaka, H., Nakamura T, Aoki T, Kojima H, Nakajima Y, Kosugi K et al. Increased plasma plant sterol levels in heterozygotes with sitosterolemia
and xanthomatosis. J. Lipid Res 1990; 31:881-88.
21. Dayal B, Ertel NH, Rapole KR, Asgaonkar A, Salen G. Rapid hydrogenation of unsaturated sterols and bile alcohols using microwaves. Steroids 1997; 62:451-4.
22. Jones PJH, Howell T, MacDougall DE, Feng JY, Parsons W. Short-Term Administration of Tall Oil Phytosterols Improves Plasma Lipid Profiles in Subjects With Different Cholesterol Levels. Metabolism 1998; 47:751-6.
23. Ling WH, Jones PJ. Dietary phytosterols: a review of metabolism, benefits and side effects. Life Sci 1995; 57(3):195-206.
24. Stefkova J, Poledne R, Hubacek JA. ATP-Binding Cassette (ABC) Transporters in Human Metabolism
and Diseases. Physiol. Res 2004; 53:235-43.
25. Klett EL, Lee MH, Adams DB, Chavin KD,
Shailendra BP. Localization of ABCG5 and ABCG8 proteins in human liver, gall bladder and intestine.
BMC Med 2004; Mar 24; 2(1): 5.
26. Yu L, Hammer RE, Li-Hawkins J, Von Bergmann K, Lutjohann D, Cohen JC et al. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in bil¬iary cholesterol secretion, Procedings Of The National Academy Of Sciences Of The United
States Of America 2002; 99(25):16237-42.
27. Shulenin S, Schriml LM, Remaley AT, Fojo S, Brewer B, Allikmets R et al. An ATP-binding cas¬sette gene (ABCG5) from the ABCG (White) gene subfamily maps to human chromosome 2p21 in the region of the Sitosterolemia locus.
Cytogenetics And Cell Genetics 2001; 92(3-4): 204-8.
28. Nguyen LB, Shefer S, Salen G, Ness GC, Tint GS,
Zaki FG et al. A Molecular Defect in Hepatic Cholesterol Biosynthesis in Sitosterolemia with Xanthomatosis. J. Clin. Invest 1990; 86:923-31.
29. Bays HE, Moore PB, Drehobl MA, Rosenblatt S, Toth PD, Dujovne CA et al. Effectiveness and Tolerability of Ezetimibe in Patients with Primary Hypercholesterolemia: Pooled Analysis of Two
Phase II Studies.Clin Ther 2001; 23:1209-30.
30. Salen G, Xu G, Tint GS, Batta AK, Shefer S.
Hyperabsorption and retention of kampestanol in a sitosterolemic homozygote: comparison with her mother and three control subjects. Journal Of
Lipid Research 2000; 41(11):1883-9.
31. Gylling H, Miettinen TA. Cholesterol Reduction by Different Plant Stanol Mixtures and With Variable
Fat Intake. Metabolism 1999; 48(5):575-80.
32. Salen G, Patel S, Batta AK. Sitosterolemia. Cardiovascular Drug Reviews 2002; 20(4):255-70.

Thank you for copying data from http://www.arastirmax.com